Patents by Inventor Laura Badi

Laura Badi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers and methods for progression prediction for chronic kidney disease
    Patent number: 10274502
    Abstract: Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: April 30, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Maria Bobadilla, Laura Badi, Guillemette Duchateau-Nguyen, Laurent Essioux, Hanno Langen, Maria Chiara Magnone, Thomas Schindler, Martina Thier, Ivan Formentini, Gonzalo Christian Duran Pacheco, Corinne Solier, Matthias Kretzler, Viji Nair, Ju Wenju
  • BIOMARKERS AND METHODS FOR PROGRESSION PREDICTION FOR CHRONIC KIDNEY DISEASE
    Publication number: 20160320410
    Abstract: Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.
    Type: Application
    Filed: October 31, 2014
    Publication date: November 3, 2016
    Inventors: Maria BOBADILLA, Laura BADI, Guillemette DUCHATEAU-NGUYEN, Laurent ESSIOUX, Hanno LANGEN, Maria Chiara MAGNONE, Thomas SCHINDLER, Martina THIER, Ivan FORMENTINI, Gonzalo Christian DURAN PACHECO, Corinne SOLIER, Matthias KRETZLER, Viji NAIR, JU Wenju
  • MARKER PROTEIN FOR TYPE-2 DIABETES
    Publication number: 20120276561
    Abstract: The present invention provides a marker protein for the early detection of type II diabetes, antibodies directed to the marker protein and their use in a diagnostic method for type II diabetes and in drug development.
    Type: Application
    Filed: November 23, 2010
    Publication date: November 1, 2012
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Laura Badi, Martin Ebeling, Hugues Matile, Cristiano Migliorini, Jacob Sabates Bellver, Thomas Schindler, Elena Sebokova, Haiyan Wang